HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR , FOCUS and PICCOLO colorectal cancer trials

Richman, Susan D, Southward, Katie, Chambers, Philip, Cross, Debra, Barrett, Jennifer, Hemmings, Gemma, Taylor, Morag, Wood, Henry +11 more·2016·The Journal of Pathology
DOI 10.1002/path.4679

Cited by (241)

Items 201–241 of 241

  1. HER2 Status in RAS and BRAF Wild-Type Metastatic Colorectal Cancer: A Portuguese Study
    Teresa Fraga, Maria João Sousa, Joana Correia Magalhães, Raquel Basto, Judy Vicente de Paulo, Nuno Bonito, José Paulo Magalhães, Paulo Figueiredo, GABRIELA MEDEIROS CELESTINO DE SOUSA · 2023 · Cureus
  2. Genomic alterations associated with early-stage disease and early recurrence in patients with colorectal cancer
    Leontios Pappas, Júlia C.F. Quintanilha, Richard S.P. Huang, Aparna R. Parikh · 2024 · The Oncologist
  3. Decoding the Genomic Report for Radiologists
    Daniel Arnold Smith, David Pfau, Sree Harsha Tirumani, Francesco Alessandrino, Navid Sadri, Nikhil H. Ramaiya · 2020 · American Journal of Roentgenology
  4. Treatment decision based on molecular profiling in metastatic colorectal cancer with a focus on RAS pathway mutations
    Johannes Schöche, Dora Niedersüß‐Beke · 2022 · memo - Magazine of European Medical Oncology
  5. The diagnostic molecular pathology of colorectal carcinoma using automated PCR
    Richard T. Colling · 2017 · UCL Discovery (University College London)
  6. Chemotherapy and Biologic Therapy in Rectal Cancer: An Update
    Rob Glynne‐Jones, Marcia Hall · 2019 · Springer eBooks
  7. Tumors of the Gastrointestinal System Including the Pancreas
    Melissa W. Taggart, Wai Chin Foo, Sun Mi Lee · 2020 · Springer eBooks
  8. Study on Prognostic Implications of HER2/Neu Expression in Colorectal Cancer in Eastern India
    Mitu Mohanty, Debahuti Mohapatra · 2020 · Journal of Evidence Based Medicine and Healthcare
  9. Development of HER2 -targeted Therapies for Gastrointestinal Cancer
    Kentaro Sawada, Yoshiaki Nakamura, Kohei Shitara · 2020 · European Oncology & Haematology
  10. ISH-basierte HER2-Diagnostik
    Josef Rüschoff, Iris Nagelmeier, Bharat Jasani, Oliver Stoß · 2020 · Der Pathologe
  11. An Introduction to the Current Management of Colorectal Cancer in the Era of Personalized Oncology
    Angelica Petrillo, Emanuela Ferraro, Michele Ghidini, Dario Trapani · 2020 · Springer eBooks
  12. Actualización de la recomendación para la determinación de biomarcadores en el carcinoma colorrectal. Consenso Nacional de la Sociedad Española de Oncología Médica y de la Sociedad Española de Anatomía Patológica
    Samuel Navarro, Míriam Cuatrecasas, Javier Hernández‐Losa, Stefania Landolfi, Eva Musulén, Santiago Ramón y Cajal, Rocio García‐Carbonero, Jesús García‐Foncillas, Pedro Pérez‐Segura, Ramón Salazar et al. · 2020 · Revista Española de Patología
  13. Systemıc Chemotherapy in Colorectal Cancer
    Olçun Ümit Ünal, Murat Keser, Baran Akagündüz · 2020 · Springer eBooks
  14. Evolving Role of Circulating Tumor DNA and Emerging Targeted Therapy in Colorectal Cancer
    Midhun Malla, Aparna R. Parikh · 2022 · Hematology/Oncology Clinics of North America
  15. Role of dual anti-HER2 therapy before liver resection for rectal metastases
    Siva Dantu, Asama Khan, Mashaal Dhir · 2022 · Journal of Surgical Case Reports
  16. Indications of Genomic Abnormalities for Molecular Targeted Therapy in Colorectal Cancer
    Koshi Mimori · 2022 · Nihon Daicho Komonbyo Gakkai Zasshi
  17. Treatment Refractory Metastatic Colorectal Cancer
    Ryan W. Huey, Kanwal Pratap Singh Raghav · 2022 · Springer eBooks
  18. HER2 ‘neu’ promise for mCRC
    Shruti Gohel, Viraj Kiran Lavingia · 2023 · International Journal of Molecular and Immuno Oncology
  19. Molecular Testing of Gastrointestinal Neoplasms
    Daniela S. Allende, Amitabh Srivastava · 2023 · Elsevier eBooks
  20. Research Progress on Colorectal Cancer Me-tastasis Mechanisms and Targeted Therapy
    玥瑶 王 · 2024 · Advances in Clinical Medicine
  21. Additional file 1 of Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
    Zaoqu Liu, Taoyuan Lu, Jing Li, Libo Wang, Kaihao Xu, Qin Dang, Chunguang Guo, Long Liu, Dechao Jiao, Zhenqiang Sun et al. · 2021 · Figshare
  22. Current treatment options of HER2+ metastatic colorectal carcinoma
    Marián Liberko, Renata Soumarová · 2024 · Onkologie
  23. Novel Therapies for Colorectal Cancers
    Muriel Battaglia, Susan L. Feldt, Marcus Marable, Ardaman P. Shergill · 2024 · IntechOpen eBooks
  24. Efficacy of disitamab vedotin-containing therapy in metastatic colorectal cancer: A case report
    Hu-Cheng Yan, Yan Liu, You Feng, Junming Li, Leiming Sheng, Xin Chen, Yuping Xie, Na Li · 2025 · World Journal of Clinical Oncology
  25. A case report of HER2-positive descending colon cancer with peritoneal metastasis and literature review
    Yaochun Lv, Zhongyang Qian, Dewang Wu, Chengzhang Zhu, Jipeng Zhang, Yeping Ning, Binbin Du · 2025 · Frontiers in Oncology
  26. Endoscopic features of deficient mismatch repair/microsatellite instability‐high and BRAF‐mutated colorectal cancer
    Rika Omote, Shizuma Omote, Ryohei Sumii, Joichiro Horii, Isao Fujita, Hideaki Miyasou, Tatsuya Toyokawa, Masaru Inagaki · 2025 · DEN Open
  27. Radical treatment for metastasis of HER2‑positive rectal adenocarcinoma to the liver: A case report and literature review
    Jiandi Huang, Zhiru Li, Dongwei He, Xin Li, Yaping Wang, Qingxia Li, Dongmiao Wang, Fan Xiaoyan · 2025 · Oncology Letters
  28. Characterization of the Tumor Immune Microenvironment in HER2-Positive Colorectal Cancer: Association With Prognostic and Therapeutic Implications
    Wen-Wen Huang, Yanjun Cheng, Shasha Yuan, Yu Liu, Furong Liu · 2025 · Clinical Colorectal Cancer
  29. Molecular Targets in Metastatic Colorectal Cancer: A Review
    Alfredo Colombo, Concetta Maria Porretto · 2025 · Indian Journal of Medical and Paediatric Oncology
  30. Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy
    Yuki Matsubara, Hideaki Bando, Yoshiaki Nakamura, Toshihiro Misumi, Dionne Ng, Eri Tajima, Harlan Pittell, Atsushi Ohtsu, Takayuki Yoshino · 2025 · British Journal of Cancer
  31. Additional file 2 of Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
    Liu, Zaoqu, Lu, Taoyuan, Li, Jing, Wang, Libo, Kaihao Xu, Dang, Qin, Guo, Chunguang, Liu, Long, 焦德超, Sun, Zhenqiang et al. · 2021 · Figshare
  32. Additional file 1 of Temporal and spatial heterogeneity of HER2 status in metastatic colorectal cancer
    Flavia D’Angelo, Franck Monnien, Alexis Overs, Irvin Pem, Fanny Dor, Marine Abad, Felix, Sophie, Zohair Selmani, Zaher Lakkis, Christophe Borg et al. · 2024 · Figshare
  33. Actionable subgroups (II): HER2+, NTRK/RET/ALK and MSI-H/TMB high
    Cristina Santos Vivas, M. Balsa Pena, David Díaz Gimeno, José Carlos Ruffinelli Rodríguez · 2026 · Revisiones en cáncer
  34. Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study
    Özlem Özdemir, Damla Günenç, Halil Taşkaynatan, Pınar Peker, Emir Gökhan Kahraman, Sedat Biter, Semra Paydaş, Tuğba Önder, Öztürk Ateş, Muhammed Muhiddin Er et al. · 2026 · Journal of Clinical Medicine
  35. HER2 overexpression/amplification in colorectal cancer: spatial intratumoral heterogeneity as a key determinant of detection discordance and therapy response
    Xiaoding Liu, Si Su, Xuqing Shi, Junyi Pang, Xinyi Teng, Longyun Chen, Hangqi Liu, Zijuan Zhang, Yaxuan Miao, Xicheng Wang et al. · 2026 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  36. Rechallenge With Anti-Human Epidermal Growth Factor Receptor 2 Therapy Guided by Liquid Biopsy in HER2 -Amplified Metastatic Colorectal Cancer
    Patricia Garcia Pastor, Javier Ros, Iosune Baraibar, Francesc Salvà, C. Salva de Torres, Ariadna Garcia, Caterina Vaghi, Josep M. Tabernero, Ana P. Vivancos, Elena Élez · 2026 · JCO Precision Oncology
  37. Integrative Profiling of Tumor and Blood Microenvironments to Uncover Molecular and Immune Determinants of Prognosis and Treatment Efficacy in Metastatic Colorectal Cancer
    Elena Benidovskaya, Nicolas D. Huyghe, Maria Virginia Giolito, Pierre G. Coulie, Marc Van den Eynde · 2026 · Cancers
  38. Unlocking HER2 as a target in KRAS-mutated rectal cancer: a case of significant response to zanidatamab-based regimen
    Kexun Zhou, Yang Yu · 2026 · Frontiers in Immunology
  39. Clinical significance of WES-defined ERBB2 amplification in resectable colorectal cancer
    Atsushi Hamabe, Yusuke Suwa, Keiji Hirata, Naoya Akazawa, Keiji Hirata, Masataka Ikeda, Mitsuru Yokota, Kentaro Kato, Masahito Kotaka, Yujiro Nishizawa et al. · 2026 · International Journal of Clinical Oncology
  40. Clinicopathological Characteristics and Prognostic Significance of High, Low, and Absent HER2 Expression Status in Colorectal Cancer
    Ethan Wright, Chloe Bennett, Jack Turner, Olivia Harris · 2026 · Archive of International Journal of Cancer and Allied Science
  41. Translating Biology into Biomarker-Driven Surgical Practice in Localized Colorectal Cancer
    Megan E. Delisle, Kilian G M Brown, J. Joshua Smith · 2026 · Surgical Oncology Clinics of North America